CPC A61K 31/4184 (2013.01) [A61P 35/00 (2018.01)] | 5 Claims |
1. A method for treating a pediatric sarcoma involving one or more translocations generating an oncogenic fusion transcription factor that requires p300/CBP for activity in a human, comprising administering a compound of formula (I):
or a pharmaceutically acceptable salt thereof to the human.
|